The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Garner Charles since 2014.
The trader's CIK number is 1602444.
At the time of the last reporting, Garner Charles was the CFO and Chief Business Officer of Recro Pharma, Inc.. (stock ticker symbol REPH).
Also see all insider trading activities at Recro Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | REPH | 2,000 | $17,000 | 0 | $0 | 0 | $0 |
| 2014 | REPH | 3,000 | $20,070 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-06-05 | REPH | Buy | 2,000 | 8.50 | 17,000 |
| 2014-05-15 | REPH | Buy | 3,000 | 6.69 | 20,070 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Garner Charles (CFO and Chief Business Officer of Recro Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.